ContributorsPublishersAdvertisers

Immunotherapy combination may benefit patients with non-small cell lung cancer resistant to single immunotherapy

MedicalXpress
 2022-01-17

Cover picture for the articleA combination of two drugs that open the floodgates to an immune system attack on cancer curtailed tumor growth in some patients with non-small cell lung cancer (NSCLC) that was resistant to a single immunotherapy agent, results from a recent clinical trial show. The addition of radiation therapy to the two-drug...

medicalxpress.com

Comments / 0

Comments / 0